Explore evidence

13.6 %Among symptomatic participants, 13.6% had moderate COVID-19 symptoms.

NigeriaCOVID-19HAL · Unilimdocument of 63 observations

SARS-CoV-2 IgGs were detected only in goats from Ebonyi and pigs from Ogun States.

NigeriaCOVID-19published 2023Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v15051187

3.52 aORHypertension was associated with increased odds of severe SARS-CoV-2 disease (adjusted odds ratio 3.52, 95% CI: 1.46–8.50).

NigeriaCOVID-19observed April to July 2020published 2022The Pan African medical journalPubMeddocument of 13 observations

0.043 p-valueThe frequency of respiratory failure was significantly higher in COVID-19 patients with diabetes mellitus (p=0.043).

NigeriaCOVID-19 · diabète (non précisé)published 2022West African journal of medicinePubMeddocument of 15 observations

50 %Diabetes was seen in 50% of patients.

NigeriaCOVID-19 · diabète (non précisé)published 2021Cardiovascular journal of AfricaPubMeddocument of 8 observations

97.5 %Most participants with positive SARS-CoV-2 RT-PCR were asymptomatic (97.5%) in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024.

Kenya · Nigeria · Ouganda · TanzanieCOVID-19observed 19 July 2022 to 1 March 2024published 2025BMC infectious diseasesPubMeddocument of 8 observations

0 deathsThere were no recorded deaths among the first 32 COVID-19 patients.

NigeriaCOVID-19observed 2020published 2020The Pan African medical journaleurope_pmcdocument of 9 observations

64.6 %The commonest symptoms were cough (42; 64.6%), breathlessness (41; 63.1%), fever (40; 61.5%), muscle aches (40; 61.5%), and anosmia (16; 24.6%).

NigeriaCOVID-19observed June 2020 to March 2021published 2022West African journal of medicinePubMeddocument of 9 observations

17.2 %Diabetes prevalence was 17.2% among RT-PCR-negative patients and 9.4% among RT-PCR-positive patients.

NigeriaCOVID-19 · diabète (non précisé)observed 27 February 2020 to 30 September 2020published 2021The Nigerian postgraduate medical journalPubMeddocument of 12 observations

9.2 %6 deaths (9.2%) were recorded among patients with advanced comorbidities and severe sepsis.

NigeriaCOVID-19observed June 2020 to March 2021published 2022West African journal of medicinePubMeddocument of 9 observations

16 %Sixteen percent (16%) of the patients were asymptomatic.

NigeriaCOVID-19observed 2020published 2020The Pan African medical journaleurope_pmcdocument of 9 observations

34.7 %Sixty (34.7%) patients had underlying medical conditions, mostly hypertension and diabetes mellitus.

NigeriaCOVID-19observed 2020published 2020West African journal of medicinePubMeddocument of 8 observations

16 %In-hospital mortality among COVID-19 patients in this single-center study was 16%.

NigeriaCOVID-19observed 2020published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 8 observations

60 %The lowest median score in any domain for Patent Medicine Stores was 60% for both post-testing phase and safety in COVID-19 antigen rapid diagnostic testing evaluation in the Federal Capital Territory of Nigeria between September 2022 and February 2023.

NigeriaCOVID-19observed September 2022 to February 2023published 2024PloS onePubMeddocument of 5 observations

22.3 %22.3% of participants were partially vaccinated against COVID-19.

NigeriaCOVID-19observed April-June 2024published 2026Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 8 observations

1.43 AORKnowing someone who died from COVID-19 was associated with increased odds of fear related to COVID-19 (adjusted odds ratio: 1.43).

NigeriaCOVID-19observed 2020published 2022Frontiers in public healthPubMeddocument of 10 observations

87 %Among the 45 COVID-19 patients, 87% were male.

NigeriaCOVID-19observed 2020published 2020The American journal of tropical medicine and hygieneeurope_pmcdocument of 8 observations

38 %The pooled prevalence of SARS-CoV-2 infection among residents of care homes and patients was 38%.

NigeriaCOVID-19published 2025Journal of public health in Africaeurope_pmcdocument of 4 observations

3.88 AORLiving with HIV was associated with increased odds of fear related to COVID-19 (adjusted odds ratio: 3.88).

NigeriaCOVID-19 · VIH/sidaobserved 2020published 2022Frontiers in public healthPubMeddocument of 10 observations

17 %The pooled mortality estimate for SARS-CoV-2 infection was 17%.

NigeriaCOVID-19published 2025Journal of public health in Africaeurope_pmcdocument of 4 observations

30.5 %Among people living with HIV in Federal Capital Territory, Nigeria, COVID-19 vaccine uptake was 30.5% in females and 46.1% in males.

NigeriaCOVID-19published 2025Transactions of the Royal Society of Tropical Medicine and HygienePubMeddocument of 3 observations

2.49 AORLiving with HIV was associated with increased odds of depression related to COVID-19 (adjusted odds ratio: 2.49).

NigeriaCOVID-19 · VIH/sidaobserved 2020published 2022Frontiers in public healthPubMeddocument of 10 observations

41,804 casesNigeria had 41,804 confirmed SARS-CoV-2 cases as of 29 July 2020.

NigeriaCOVID-19observed 29 July 2020HAL · Unilimdocument of 97 observations

97 %Almost all (97%) the patients were treated with lopinavir-ritonavir.

NigeriaCOVID-19observed 2020published 2020The Pan African medical journaleurope_pmcdocument of 9 observations

1.125 odds_ratioThe odds of a patient with diabetes and COVID-19 developing acute kidney injury were 1.125 (95% CI 1.025–1.621).

Nigeriaacute kidney injury · COVID-19 · diabète (non précisé)published 2022West African journal of medicinePubMeddocument of 15 observations